Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 413 of 6351
-
New hope for tough bladder cancer: experimental drug SYS6002 faces chemo in major trial
Disease control Not yet recruitingThis study is a randomized, controlled, open-label, multicenter phase III clinical trial, which aims to evaluate the efficacy,safety PK characteristics, and immunogenicity of SYS6002 compared with chemotherapy in participants with locally advanced or metastatic urothelial carcino…
Phase 3 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New hope for bladder cancer: targeted drug combo aims to boost survival
Disease control Not yet recruitingThis is a multicenter, randomized controlled clinical trial (HOPE-07) designed to evaluate the efficacy and safety of perioperative treatment with disitamab vedotin (RC48) combined with toripalimab compared with toripalimab combined with chemotherapy in patients with resectable H…
Phase 2/3 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Targeted radiation delivered directly to brain tumor cavity in new trial
Disease control Recruiting nowThe primary objective of this study is to evaluate the dosimetry, safety, and tolerability of the investigational radiopharmaceutical \[177Lu\]Lu-XT771 in patients with recurrent glioblastoma, an aggressive form of brain cancer. \[177Lu\]Lu-XT771 is designed to specifically targe…
Early phase 1 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Diabetes drug may double as brain protector in new trial
Disease control OngoingThis study is a prospective, randomized, open-label trial with blinded outcome assessment (PROBE design) designed to evaluate the effects of sodium-glucose cotransporter-2 (SGLT2) inhibitor therapy on cognitive function in adults with type 2 diabetes mellitus (T2D). A total of 20…
Sponsor: University of Primorska • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could a thyroid boost help tiny preemies grow smarter and stronger?
Disease control Not yet recruitingThe primary objective of this clinical trail is to evaluate whether early supplementation of levothyroxine (L-T4) at a dosage of 8 ug/kg/d, initiated in the second week of life, improves physical growth and neurodevelopmental outcomes at 2 years of corrected age in Small for Gest…
Sponsor: Shandong Provincial Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New drug QLC5508 takes on chemo in prostate cancer battle
Disease control Not yet recruitingThis is a randomized, open-label, active-controlled, multicenter Phase III trial evaluating QLC5508 versus docetaxel in participants with metastatic castration-resistant prostate cancer (mCRPC) who have progressed after prior treatment with novel hormonal agents (NHAs). Participa…
Phase 3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Can a new drug tame tumors that resist standard therapy?
Disease control Recruiting nowThis study is to evaluate the tolerability and safety of ONO-7429 in participants with unresectable advanced or recurrent solid tumors.
Phase 1 • Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Blood test could guide anal cancer treatment, reducing side effects
Disease control Recruiting nowThis study is for people who have anal cancer and have not yet had treatment. The regular treatment for people who have anal cancer is chemoradiation therapy (CRT). CRT is when chemotherapy and radiation therapy are given at the same time. Studies show that CRT works well to trea…
Phase 2 • Sponsor: Jennifer Dorth • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New weight loss pill enters final testing phase in china
Disease control Recruiting nowThis study is a multicenter, randomized, double-blind, placebo-controlled Phase III clinical study aimed at evaluating the efficacy, safety, and pharmacokinetic (PK) characteristics of DA-302168S tablets in overweight or obese participants in China.
Phase 3 • Sponsor: Chendu DIAO Pharmaceutical Group CO., LTD. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New pill could regrow hair in severe alopecia – trial begins
Disease control Recruiting nowThis study evaluates the efficacy and safety of deuruxolitinib in Japanese Adults between 18 and 65 years of age who have 50% or greater scalp hair loss.
Phase 3 • Sponsor: Sun Pharma Japan Limited • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
AI ultrasound could bring lifesaving pregnancy checks to remote villages
Diagnosis Recruiting nowFS2 evaluates the diagnostic accuracy and implementation feasibility of an AI-assisted blind-sweep obstetric ultrasound (SPAQ E-con AI), operated by trained non-specialist health workers, for antenatal screening in rural Democratic Republic of the Congo. Primary outcomes are gest…
Sponsor: SOIK Corporation Sarl • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
Can a new drug boost Semaglutide's power against diabetes and obesity?
Disease control Recruiting nowThe goal of this clinical trial is to learn if AT673 contributes to additional weight loss and glycemic control when given with semaglutide in participants with overweight/obesity and type 2 diabetes. The main questions it aims to answer are: * To compare the effect on body weig…
Phase 2 • Sponsor: Antag Therapeutics • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New hope for tough ovarian cancer: phase 3 trial of Mo-Rez drug launches
Disease control Recruiting nowThis study specifically aims to evaluate how well mocertatug rezetecan (Mo-Rez) works in treating ovarian cancer compared to standard treatments. The study also assesses whether Mo-Rez is safe and tolerated well by participants compared to standard treatments and aims to provide …
Phase 3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Sleep therapy could be key to preventing suicide in young adults
Symptom relief Recruiting nowThe purpose of this study is to examine the extent to which delivering sleep and circadian focused interventions in addition to evidenced based psychiatric care for depression and suicide risk may contribute to decreasing suicide risk among high risk young adults. Investigators w…
Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
MRNA vaccine aims to shield transplant patients from EBV threat
Prevention Not yet recruitingThe purpose of this clinical trial is to investigate the efficacy of the EBV mRNA vaccine (WGc-0401 injection) in preventing EBV-related diseases after allogeneic hematopoietic stem cell transplantation (allo-HSCT), and to evaluate the safety and efficacy of this vaccine in patie…
Early phase 1 • Sponsor: The General Hospital of Western Theater Command • Aim: Prevention
Last updated Jul 01, 2026 00:00 UTC
-
Can a smartphone app replace physiotherapy for knee pain?
Disease control Recruiting nowSymptomatic osteoarthritis (OA) of the knee affects approximately one-fifth (\~300K) of Singaporeans aged 50 years or older, with the disease prevalence increasing with age. Patients with advanced knee OA and severe disability often require a total knee replacement (TKR) surgery.…
Sponsor: Singapore General Hospital • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Brain zaps after trauma may stop PTSD before it starts
Prevention Recruiting nowPTSD is one of the most universal and severe psychiatric disorders whose incidence continues to rise due to the common exposure to severe trauma in the United States and worldwide. After trauma, a proportion of individuals maintains high symptoms of PTSD and depression, which can…
Sponsor: Emory University • Aim: Prevention
Last updated Sep 10, 2026 00:00 UTC
-
New inhaled treatment aims to save lungs and reduce ventilator time in ICU patients
Disease control Recruiting nowThis is a multicentre, double-blind, placebo-controlled Phase III randomized clinical trial designed to evaluate the efficacy and safety of inhaled aprotinin in adult patients with moderate or severe acute respiratory distress syndrome (ARDS). A total of 156 critically ill patien…
Phase 3 • Sponsor: Fundacion del Hospital Nacional de Paraplejicos para la Investigacion y la Integracion • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New study pits Clot-Removal devices against drugs for dangerous lung clots
Disease control Recruiting nowThe STRATIFY II trial investigates the efficacy of three different approaches to reducing thrombus burdon in patients with acute intermediate high-risk pulmonary embolism: percutaneous embolectomy (the AlphaVAC(R), AngioDynamics or the Flow Triever® system, INARI medical), Low in…
Phase 3 • Sponsor: Jesper Kjaergaard • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could direct heart pacing beat standard therapy for heart failure?
Disease control Recruiting nowThe NORDIC-CSP trial is an investigator-initiated, blinded, nordic RCT aimed at evaluating whether using direct pacing of the HIS bundle (HIS)-pacing or left bundle branch (LBB) pacing is superior to conventional biventricular pacing in reducing the incidence of the composite end…
Sponsor: Rigshospitalet, Denmark • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC